Bahareh Bahadini, M.D.
- Hematology-Oncology
- Breast Cancer
- Gastrointestinal Cancers
- Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research
Bahareh Bahadini, M.D., brought her expertise in hematology and oncology to City of Hope® in 2014 after more than a decade at North Valley Hematology/Oncology Group in Mission Hills, California. Dr. Bahadini’s training includes a residency at St. Mary Medical Center and a fellowship in hematology and oncology at City of Hope, including a year of research investigating genetic factors involved in breast cancer. She received her doctorate from the USC School of Medicine and received Master of Science degrees in both pathology and applied physiology at the University of Health Sciences/Chicago Medical School.
Dr. Bahadini founded and has been actively involved in the Wellness Through Awareness integrative medicine program at Providence Holy Cross Medical Center since 2007.
Location
Simi Valley
Simi Valley, CA 93065
Thousand Oaks
Suite 101
Thousand Oaks, CA 91361
Education & Experience
Board Certifications
- 2003, Board Certified in Oncology
- 2001, Board Certified in Internal Medicine
- 2001, Board Certified in Hematology
Degrees
- 1996, M.D., Keck School of Medicine of USC, Los Angeles, CA
- 1994, Master of Science, Pathology, Finch University of Health Sciences/Chicago Medical School, Chicago, IL
- 1992, Master of Science, Applied Physiology, Finch University of Health Sciences/Chicago Medical School, Chicago, IL
- 1990, BA, Chemistry, California State University, Long Beach, CA
Fellowship
- 2001–2004, Hematology, Oncology and Therapeutics, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
Residency
- 1997–1999, Internal Medicine, Saint Mary Medical Center, Harbor-UCLA Medical Center Affiliation, Long Beach, CA
Internship
- 1996–1997, Internal Medicine, Saint Mary Medical Center, Harbor-UCLA Medical Center Affiliation, Long Beach, CA
Professional Experience
- 2018–present, Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
- 2015–present, Member, Gastrointestinal and Breast Cancer Team, City of Hope, Duarte, CA
- 2014–2018, Staff Physician, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
- 2006–present, Founder, Wellness Through Awareness, a nonprofit organization, Providence Holy Cross Medical Center, Mission Hills, CA
- 2004–2014, Private Practice, North Valley Hematology/Oncology Group, Mission Hills, CA
- 2005–2010, Assistant Clinical Professor, Hematology/Oncology, Olive View Medical Center, Sylmar, CA
Awards & Memberships
Awards
- 2003, Amgen Research Fellowship Award
Memberships
- 2009, Anticoagulation Committee, Providence Holy Cross Medical Center
- 2007, Chairman Cancer Committee, Providence Holy Cross Medical Center
- 2003, American Society of Clinical Oncology
- 2003, American Society of Hematology
- 2002, American Medical Association
- 2002, American College of Physicians
Publications
- Pham A, Bahadini B, Alsabeh R, Steinberg A. First reported case of aplastic anemia occurring in a patient after acute promyelocytic leukemia in remission. Clin Adv Hematol Oncol. 2009 Oct;7(10):670-4. PMID: 20040907.
- Karimi M, Wang C, Bahadini B, Hajjar G, Fakih M. Integrating Academic and Community Practices in the Management of Colorectal Cancer: The City of Hope Model. J Clin Med. 2020 Jun 2;9(6):1687. doi: 10.3390/jcm9061687. PMID: 32498251; PMCID: PMC7357113.
- Gray SW, Ottesen RA, Currey M, Cristea M, Nikowitz J, Shehayeb S, Lozano V, Hom J, Kilburn J, Lopez LN, Wing S, Sosa E, Shen J, Morris M, Dilsizian B, Joseph T, Shen J, Adeimy C, Phillips T, Bahadini B, Niland JC. Leveraging an Informatics Approach to Identify an Unmet Clinical Need for BRCA1/2 Testing Among Patients With Ovarian Cancer. JCO Clin Cancer Inform. 2022 Sep;6:e2200034. doi: 10.1200/CCI.22.00034. PMID: 36049148; PMCID: PMC9470148.
- Semeniuk G, Bahadini B, Ahn E, Zain J, Cheng J, Govindarajan A, Rose J, Lee RT. Integrative Oncology and the Clinical Care Network: Challenges and Opportunities. J Clin Med. 2023 Jun 9;12(12):3946. doi: 10.3390/jcm12123946. PMID: 37373639; PMCID: PMC10299099.